Pandemics & Infectious Diseases
Medical Treatment & Drug Development
Influenza
Vaccines
Post-Doctoral Fellowships
France
2013.03.31
A Synthetic System of Molecular Co-evolution
It is difficult to develop vaccines for human parasites such as HIV, influenza and hepatitis C because both the parasites and the immune system of the host evolve quickly. Dr. Dipanwita Biswas seeks to quantify the degree of predictability of this co-evolution by setting up a controlled model system that mimics the evolutionary dynamics between influenza and its host. Her results could help advance the development of vaccine design strategies that take viral mutations into account before they actually occur.
A new approach to quantify the evolution of parasites
To add or modify information on this page, please contact us at the following address: community.research@axa.com
Dipanwita
BISWAS
Institution
Université Joseph Fourier - Grenoble 1
Country
France
Nationality
Indian
Related articles
Chronic & Non Communicable Diseases
Medical Treatment & Drug Development
Chronic Pain & Musculoskeletal Disorders
Drug Delivery
Biotech- and Nanotechnology
AXA Project
France
Pain Pediatric & Elderly AXA Research Lab (PEARL)
Chronic pain is recognized as a major public health problem affecting patients in their daily activity, physical and mental health,... Read more
Celine
GRECO
Hôpital Necker-Enfants Malades
Medical Treatment & Drug Development
Drug Delivery
Biotech- and Nanotechnology
Mécénat des Mutuelle
France
Accelerating drug innovation with the Euridis school and its DDD Challenge
The project addresses a dual challenge: on one hand, the increasing complexity of drug development, which requires a thorough understanding... Read more
Laurence
SABATIER